Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-22-008780

Chief Discovery Officer sold 20,000 shares at $17.16 ($343,200)

From the SEC's structured data for this filing

Trades in this filing

Babu Yarlagadda S · Chief Discovery Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-07 Sale : show line 1 in the form −20,000 $17.16 $343,200 230,056 D
Open-market sales · 20,000 sh · avg $17.16 · $343,200
Loading xslF345X03/form4.xml…